General Condition Information
- Benign hyperphenylalaninemia (due to biopterin defect in co-factor regeneration)
- Biopterin Cofactor Defects
- Biopterin cofactor regeneration defect
- Biopterin defect
- Defect of biopterin cofactor regeneration
- Defects of biopterin cofactor regeneration
- Tetrahydrobiopterin deficiency
- This condition is one type of a group of rare conditions known as tetrahydrobiopterin deficiencies. Only a few babies are born with tetrahydrobiopterin deficiencies in the United States per year.
- This condition is more common in babies of Saudi Arabian, Taiwanese, Chinese, or Turkish descent.
What is Biopterin defect in cofactor regeneration
Biopterin defect in cofactor regeneration is an inherited (genetic) condition that increases levels of a substance called phenylalanine in the blood. Phenylalanine is one kind of amino acid, which are the building blocks of protein. Your body uses amino acids to make other proteins that it needs to function.
Cofactors are substances that help enzymes work. Tetrahydrobiopterin (BH4), which is a type of biopterin, is a cofactor that helps certain enzymes process phenylalanine and important brain chemicals. Your body needs to build and recycle BH4 correctly for these important enzymes to work. Biopterin defect in cofactor regeneration occurs when the body cannot recycle (regenerate) BH4.
Biopterin defect in cofactor regeneration is one of a group of conditions called tetrahydrobiopterin deficiencies. Another condition in this group is called Biopterin Defect in Cofactor Biosynthesis, which occurs when BH4 is not built correctly.
Two enzymes in your body help recycle BH4. In biopterin defect in cofactor regeneration, one of these two enzymes does not work well. This condition will be more or less severe depending on which enzyme is not working well. Without working BH4, the processes that need this cofactor cannot do important jobs in the body.
Babies with biopterin defect in cofactor regeneration cannot break down all the phenylalanine from the proteins they eat. As a result, phenylalanine builds up to harmful levels in their body. Their body also makes fewer important chemicals for their brain called neurotransmitters. This can cause the signs and symptoms of the condition.
Newborn Screening and Follow-Up
Newborn screening for biopterin defect in cofactor regeneration is done using a small amount of blood collected from your baby’s heel. To learn more about this process, visit the Blood Spot Screening page.
During screening, a special machine measures how much of a substance called phenylalanine is in your baby’s blood. In most cases, babies with high levels of phenylalanine have a condition called classic phenylketonuria (PKU). But, in some rare cases, babies with high levels of phenylalanine are found to have biopterin defect in cofactor regeneration. Whether a baby has PKU or a biopterin defect will be determined during follow-up testing.
If your baby’s blood spot screening result for biopterin defect in cofactor regeneration is out-of-range, your baby’s health care provider will contact you. Together, you will discuss next steps and follow-up plans.
An out-of-range screening result does not mean that your baby definitely has the condition. It does mean that your baby needs more follow-up testing. To learn more about screening results, visit the Blood Spot Screening Results page.
Your baby may need the following tests after an out-of-range screening result:
- Blood and/or urine tests
- Genetic testing using a blood sample
You should complete any recommended follow-up testing as soon as possible. Babies with this condition can have serious health problems soon after birth if they are not diagnosed and treated quickly.
False-positive newborn screening results for this condition are rare. However, babies who receive supplemental nutrition (also called total parenteral nutrition [TPN] or hyperalimentation) may have out-of-range results.
Newborn screening helps babies lead healthier lives. If your baby has an out-of-range result, follow up with your health care provider quickly. It is important to follow their instructions. Your baby may need to get treatment right away, even if they are not showing signs or symptoms. In some cases, your baby’s health care provider may decide it is best to watch (monitor) your baby to decide next steps. Careful monitoring and early treatment will help your baby stay as healthy as possible.
Babies with biopterin defect in cofactor regeneration often seem healthy at birth, but they may develop signs of the condition over time. Eating foods with high amounts of phenylalanine (protein-containing foods), illness, infection, or going a long time without eating can trigger signs of the condition.
Signs of the condition may include the following:
- Delays in development
- Weak muscle tone (hypotonia)
- Difficulty swallowing
- Problems with controlling body temperature
- Sleepiness (lethargy)
- Behavioral problems
Biopterin defect in cofactor regeneration is caused by changes in one of two genes, called PCBD1 or QDPR. These genes give the body instructions to make two enzymes that help recycle BH4, called pterin-4-alpha-carbinolamine dehydratase (PCD) and dihydropteridine reductase (DHPR).
The body cannot recycle enough normal BH4 without working PCBD1 or QDPR genes. Without enough working BH4, the body cannot break down phenylalanine and the brain cannot function as it should.
If DHPR is the enzyme that does not work well, the condition is more severe. If PCD is the enzyme that does not work well, the condition is less severe.
- Biopterin defect in cofactor regeneration is an autosomal recessive condition. Babies inherit the condition when each parent passes down the same nonworking gene that causes biopterin defect in cofactor regeneration (PCBD1 or QDPR) to their baby. Only babies with two matching nonworking genes—for example, one nonworking PCBD1 from the mom and one nonworking PCBD1 from the dad—have this condition. Babies with two nonworking genes that do not match—for example, one nonworking PCBD1 from the mom and one nonworking QDPR from the dad—will not have this condition.
- People with one working copy and one nonworking copy of the PCBD1 or QDPR gene are called carriers.
- Carriers do not have or develop the condition. However, they may pass down a nonworking copy of the gene to their children.
- If two parents are carriers of a nonworking copy of the PCBD1 or QDPR gene, they have a 1 in 4 chance of having a child with biopterin defect in cofactor regeneration.
- Carriers for biopterin defect in cofactor regeneration often do not know they are carriers before having a child with the condition. In most cases, families have no history of the condition until the birth of a child with biopterin defect in cofactor regeneration.
- Parents who already have a child with biopterin defect in cofactor regeneration still have a 1 in 4 chance of having another child with biopterin defect in cofactor regeneration. This 1 in 4 chance stays the same for all future children.
- Genetic counselors and medical geneticists can help families learn about this condition and the chance of having children with it. Visit the National Society of Genetic Counselors to find a genetic counselor and the American College of Medical Genetics and Genomics to find a medical geneticist.
Treatment and Management
It is important to talk to your health care provider about which treatment(s) are best for your baby. The goal of treatment is to prevent the health problems caused by this condition.
Treatments may include the following:
- Restricted diet that avoids foods with phenylalanine
- Medical formula and foods
- BH4 supplements to reduce phenylalanine levels
- Medicine to help/increase neurotransmitter levels
Children who receive early and ongoing treatment for biopterin defect in cofactor regeneration can have healthy growth and development.